Table 1 Baseline information on the patients with AGel amyloidosis in the FIN-GAR phase II registry
Number of patients | 261 |
|---|---|
Gender distribution | 183 (70%) female, 78 (30%) male |
Mean age of the patients | 62.7 years (range 26.3–85.8 years) |
Median age of the patients | 64.7 years (interquartile range 54.9–71.2 years) |
Mean age at diagnosis of AGel amyloidosis | 40.7 years (range 10.4–68.7 years) |
Genetic testing done | 138 (53%) |
Follow-up time after FIN-GAR phase I | 4.9 years (range 4.1–5.6 years) |